Night Sweats and Sleep: Treatment Options Compared

Short answer: Night-dominant vasomotor symptoms respond to bedtime-weighted treatment: micronized progesterone or gabapentin at night, transdermal estradiol for continuous coverage, or fezolinetant when hormones are unsuitable. Cooling strategies help at the margins but do not replace treatment.

Bedtime-weighted options

Micronized progesterone 200–300 mg at bedtime — sedating and endometrium-protective.
Gabapentin at night — reduces nocturnal events and deepens slow-wave sleep.
Transdermal estradiol — steady 24-hour levels, no overnight trough.
Fezolinetant — hormone-free, separates from placebo within the first week.

Environmental measures worth doing

Bedroom at 16–18 °C; a cool room genuinely widens the thermoneutral margin.
Layered, moisture-wicking bedding rather than a single heavy duvet.
No alcohol within three hours of bed.
A cool shower before bed lowers core temperature on the rebound.

← Back to the menopause sleep hub

Sleeping badly and tired of being handed a hygiene leaflet? A Kindr clinician will screen for apnoea, treat the driver, and set up CBT-I.

Start your visit →

Not ready? Ask Dot, our free AI menopause companion.

Frequently asked questions

Why are my flashes worse at night?

Core temperature falls overnight and the thermoneutral zone narrows further, so a smaller temperature rise triggers a full heat-dissipation response.

Can I treat only at night?

Yes for gabapentin and progesterone. Estradiol and fezolinetant provide continuous coverage and are dosed accordingly.

The menopause sleep hub

Mechanism, CBT-I, night sweats, apnoea, treatment comparison, and what sleep hygiene misses.

Pillar guide →Every treatment for menopausal sleep disruption, ranked by randomized trial evidence — plus a sleep severity quiz, a time-to-improvement timeline, and the screening step that changes the plan for one woman in four.Why menopause breaks sleep →Vasomotor arousals, allopregnanolone loss, thermoregulation, and conditioned arousal.CBT-I: the first-line treatment →What sleep restriction and stimulus control actually involve, week by week.Night sweats and sleep →Treating the waking event: hormonal and hormone-free options for night-dominant symptoms.Sleep apnoea after menopause →Prevalence roughly triples, women present atypically, and it is routinely missed.Treatments compared →CBT-I, hormones, non-hormonal prescriptions, supplements, and sedatives ranked by evidence.What sleep hygiene misses →Why generic advice fails menopausal insomnia, and the parts that do matter.

Other Kindr symptom hubs

The brain fog hub →Menopause weight gain: causes and treatment →Peptide therapy: evidence, legality, and safety →The hot flashes hub →

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

Sources

McCurry SM et al. Telephone-based CBT for insomnia in perimenopausal and postmenopausal women (MsFLASH 03). JAMA Intern Med 2016.
Ensrud KE et al. Effects of estradiol and venlafaxine on insomnia symptoms (MsFLASH). Sleep 2015.
Caufriez A et al. Progesterone prevents sleep disturbances in postmenopausal women. J Clin Endocrinol Metab 2011.
Kravitz HM et al. Sleep difficulty in women at midlife (SWAN). Menopause 2008.
Young T et al. Menopausal status and sleep-disordered breathing. Am J Respir Crit Care Med 2003.
The Menopause Society. 2023 Nonhormone Therapy Position Statement.
American Academy of Sleep Medicine. Clinical Practice Guideline for Behavioral Treatment of Chronic Insomnia.

Educational content only — not a substitute for professional medical advice, diagnosis, or treatment. The severity quiz is a screening aid, not a diagnosis. Reviewed by the Kindr Health clinical team · Last reviewed 2026-07-26.